The 2020 ACC/AHA Guidelines for Management of Patients With Valvular Heart Disease: Highlights and Perioperative Implications
Recommended Citation
Mohananey D, Aljadah M, Smith AAH, Haines JF, Patel S, Villablanca P, and Ramakrishna H. The 2020 ACC/AHA Guidelines for Management of Patients With Valvular Heart Disease: Highlights and Perioperative Implications. J Cardiothorac Vasc Anesth 2022; 36(5):1467-1476.
Document Type
Article
Publication Date
5-1-2022
Publication Title
Journal of cardiothoracic and vascular anesthesia
Abstract
Valvular heart disease contributes to a large burden of morbidity and mortality in the United States. During the last decade there has been a paradigm shift in the management of valve disease, primarily driven by the emergence of novel transcatheter technologies. In this article, the latest update of the American College of Cardiology/American Heart Association valve heart disease guidelines is reviewed.
Medical Subject Headings
American Heart Association; Cardiology; Heart Valve Diseases; Humans; United States
PubMed ID
34011447
Volume
36
Issue
5
First Page
1467
Last Page
1476
